Abstract:Objective: To explore the feasibility and accuracy of 0-1 h high sensitivity cardiac troponin I (hs-cTnI) concentration and its changes in judging non-ST segment elevation myocardial infarction (NSTEMI), and to investigate the feasibility of a simplified process. Methods: Patients with acute chest pain and suspected NSTEMI who were admitted to the emergency department of Fuwai Hospital, the First Affiliated Hospital of Sun Yat-sen University and Nanjing First Hospital from January 2017 to September 2020 were selected. Hs-cTnI test was carried out for the selected patients at the time of visit (0 h) and 1 h after visit. According to the 0-1 h hs-cTnI diagnostic process and threshold standard recommended by European Society of Cardiology (ESC) guidelines in 2015, the laboratory adjudication was determined. Cardiologists who did not participate in the project design and did not know the results of hs-cTnI test performed the clinical judgment according to the routine diagnosis and treatment process of emergency department. Taking clinical judgment as the gold standard, the diagnostic efficacy of 0-1 h hs-cTnI concentration and its change recommended by the guidelines for judging NSTEMI in Chinese population was analyzed. The guide process was simplified. Under the condition of not considering the time of chest pain, the guideline threshold was used for test and judgement, and the diagnostic efficacy of the simplified process was evaluated. Results: A total of 1 534 patients were enrolled in the study, aged (62±12) years and 952 (62.1%) patients were male. Among them, 402 patients (26.2%) were clinically diagnosed as NSTEMI and 1 132 patients (73.8%) were diagnosed as non-NSTEMI. According to the diagnosis and determination process recommended by the guidelines, NSTEMI was excluded in 672 patients (42.8%), and 464 patients (30.2%) were diagnosed as NSTEMI. The consistency rate with clinical determination reached 92.4% (1 050/1 136), the sensitivity of excluding diagnosis was 99.5% (95%CI: 98.0%-99.9%), the negative predictive value was 99.7% (95%CI: 98.8%-99.9%), and the negative likelihood ratio was 0.008 (95%CI: 0.002-0.335). The diagnostic specificity was 92.6% (95%CI: 90.9%-94.0%), the positive predictive value was 81.9% (95%CI: 78.0%-85.2%), and the positive likelihood ratio was 12.739 (95%CI: 10.356-15.670). According to the simplified process, NSTEMI was excluded in 675 patients (44.0%), and 463 patients (30.2%) were diagnosed as NSTEMI. The consistency rate with clinical judgment was 92.4% (1 051/1 138), the sensitivity of exclusion diagnosis was 99.3% (95%CI: 97.6%-99.8%), the negative predictive value was 99.6% (95%CI: 98.6%-99.9%), and the negative likelihood ratio was 0.012 (95%CI: 0.004-0.389). The diagnostic specificity was 92.6% (95%CI: 90.9%-94.0%), the positive predictive value was 81.9% (95%CI: 78.0%-85.2%), and the positive likelihood ratio was 12.705 (95%CI: 10.328-15.630). There was no significant difference in diagnostic efficacy between the simplified process and the recommended process (all P>0.05). Conclusion: The diagnostic process for judging NSTEMI according to the 0-1 h hs-cTnI concentration and its change criteria recommended by the 2015 ESC guidelines is applicable in the Chinese population and remains highly accurate in judging NSTEMI without considering the duration of chest pain at the time of presentation.

Diagnostic Value of Combined Measurement of TnI,hs-CRP and NT-proBNP by ROC Curve in Elderly Patients with Acute Coronary Syndrome

The Study of the Relation Between C-reactive Protein,fibrinogen and Acute Coronary Syndrome

The diagnostic value of IL-6,NT-proBNP and hs-CRP for acute coronary syndromes patients

Clinical Value of Combined Detection of CK-MB, MYO, Ctni and Plasma NT-proBNP in the Diagnosis of Acute Myocardial Infarction

Value of N-terminal pro-B-type natriuretic peptide level to the early diagnosis of acute coronary syndrome

Application of Enhanced Cardiac Troponin Ⅰ Determination in Clinical Diagnosis of Acute Coronary Syndrome

Diagnostic Value of cTnl, NT-pro BNP, and Combined Tests in Acute Myocardial Infarction Patients

Clinical value of combined detection of serum total sialic acid, sialidase and high sensitivity C-reactive protein in patients with acute myocardial infarction

Clinical Value of High Sensitivity Cardiac Troponin T in the Diagnosis of Acute Myocardial Infarction

Value of N - terminal Pro - B - type Natriuretic Peptide Combined with Total Coronary Calcification Score in Evaluating the Risk of Prognosis among Elderly Patients with Stable Coronary Artery Disease

Value of biochemical marker detection in risk stratification in patients with acute coronary syndrome]

Clinical Implication of Mildly Elevated Serum Hs-Tnt in Elderly Patients with Acute Coronary Syndrome

Clinical Value Analysis of Combined NT-pro BNP hs-CRP and D-D in Acute Myocardial Infarction

Application of Combined Detection of Three Markers in Assessment of Acute Coronary Syndromes

Evaluation of clinical performance of cardiac troponin Ⅰ in diagnosis and prognosis of non-ST elevation acute coronary syndromes

Clinical Value of Combined Detection of Serum Total Sialic Acid ,High Sensitivity C-reactive Protein and Homocysteine in Patients with Acute Cerebral Infarction

Levels of Neopterin, D-Dimer and High-Sensitivity C-Reactive Protein in Serum of Patients with Acute Coronary Syndrome

The significance of high-sensitivity troponin T measurement in the diagnosis of elderly patients with acute myocardial infarction

The Clinical Significance on the Combined Determination of NT-proBNP,H-FABP and Ctni in Elder Patients with Severe Heart Failure

High-sensitivity cardiac troponin T for early prediction of non-ST-segment elevation myocardial infarction in patients with suspected acute coronary syndrome

[Efficacy Analysis of High-Sensitivity Troponin I Concentration and Its Changes in the Diagnosis of Acute Myocardial Infarction].